Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared some top articles.
1. “Hot off the press in ASCO, JCO Oncology Advances.
Pleased to share our study ‘Impact of FDA Project Optimus Guidance on Design of Early-Phase Clinical Trials’
- Analysis of 367 phase I oncology trials (2021-2024) reveals Project Optimus is transforming cancer drug development:
- Bayesian designs surged 48% → 75%
- 30% now include dose-optimization plans
Moving beyond max tolerated dose approach
This shift toward smarter, more patient-centered trial design marks a pivotal moment in early-phase cancer research”
Title: Impact of Food and Drug Administration Project Optimus Guidance on Design of Early-Phase Clinical Trials
Journal: JCO
Authors: Deepak Bhamidipati, Suzanne Jones, David Spigel, Gerald Falchook, Manish Patel, Howard Burris, and Vivek Subbiah
2. Title: EML4-ALK variant-specific genetic interactions shape lung tumorigenesis
Journal: Cancer Discovery
Authors: Alberto Diaz-Jimenez, Emily G. Shuldiner, Kalman Somogyi, Karen Shih, Oscar Gonzalez-Velasco, Mulham Najajreh, Stewart Kim, Filiz Akkas, Christopher W. Murray, Laura Andrejka, Min K. Tsai, Benedikt Brors, Ilse Hofmann, Smruthy Sivakumar, Saumya D. Sisoudiya, Ethan S. Sokol, Hongchen Cai, Dmitri A. Petrov, Monte M. Winslow, and Rocio Sotillo
3. Title: The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer
Journal: Cancer Discovery
Authors: Marco Avolio, Simonetta M. Leto, Francesco Sassi, Barbara Lupo, Elena Grassi, Irene Catalano, Eugenia R. Zanella, Valentina Vurchio, Francesca Cottino, Petros K. Tsantoulis, Luca Lazzari, Paolo Luraghi, Martina Ferri, Francesco Galimi, Enrico Berrino, Sara E. Bellomo, Marco Viviani, Alberto Sogari, Gianluca Mauri, Federica Tosi, Federica Cruciani, Andrea Sartore-Bianchi, Salvatore Siena, Felice Borghi, Valter Torri, Elena Élez, Josep Tabernero, Maria Nieva, Clara Montagut, Noelia Tarazona, Andres Cervantes, Sabine Tejpar, Alberto Bardelli, Caterina Marchiò, Silvia Marsoni, Andrea Bertotti, and Livio Trusolino
4. Title: Translating Artificial Intelligence Breakthroughs into Cancer Diagnostic Breakthroughs
Journal: Cancer Discovery
Authors: Juan M. Lavista Ferres, Elliot K. Fishman, Ed Catmull, Bert Vogelstein, and Joshua T. Vogelstein
5. Title: When AI rejects your grant proposal: algorithms are helping to make funding decisions
Journal: Nature
Authors: David Adam
More from Vivek Subbiah on OncoDaily.